Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease
Abstract
Abstract. Background: Nonalcoholic fatty liver disease (NAFLD) is a serious global health problem, thus the prevention and management of the disease is necessary. This study aimed to determine the effects of Ramadan Fasting (RF) on liver function, Visceral Adiposity Index (VAI) and Atherogenic Index of Plasma (AIP) in these patients.
Methods: Eighty-three NAFLD patients (57 males and 26 females) were enrolled in the study, 42 patients who practiced RF, between Jun 18 through July 17, 2015 and 41 patients in non-fasting groups. Anthropometric parameters and Ultrasound grading were measured before and after Ramadan. The biochemical parameters including lipid profiles (total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides), liver enzymes (Aspartate aminotransferase, SGOT and Alanine aminotransferase, SGPT) were evaluated before and after Ramadan. AIP and VAI were calculated based on formula.
Results: The mean decreases in anthropometric indices were significantly different between groups. Similarly, the mean decrease in the total cholesterol values in the fasting group was remarkably greater than in the control group (p = 0.02). The values of AIP and VAI decreased at the end of the study in both group and the mean of changes showed no differences between groups (p = 0.79 and p = 0.65 for AIP and VAI, respectively). The changes in the concentrations of liver enzymes, as well as the severity of hepatic steatosis, showed remarkable differences between groups (p = 0.03, p = 0.05, and p = 0.02 for SGOT and SGPT, and Liver steatosis, respectively).
Conclusion: RF improved liver steatosis in NAFLD patients and might be useful in the management of NAFLD.
References
1 (2013) NAFLD, NASH and liver cancer. Nature Reviews Gastroenterology and Hepatology. 10(11), 656–665.
2 (2016) Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR). International Journal of Molecular Sciences. 17(7), 1192.
3 (2015) Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study. Hepatology. 61(4), 1205–1215.
4 (2011) Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. Bmj. 343, d6891–0000.
5 (2014) Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol. 6(11), 800–811.
6 (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 51(1), 121–129.
7 (2014) Effect of Ramadan fasting on serum concentration of apelin-13 and new obesity indices in healthy adult men. Medical Science Monitor. 20, 337–342.
8 (2014) The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases. European Journal of Clinical Nutrition. 68(7), 835–839.
9 (2014) Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. International Journal of Obesity. 38(6).
10 (2014) Visceral adiposity index: an indicator of adipose tissue dysfunction. International Journal of Endocrinology. 2014.
11 (2010) Visceral Adiposity Index A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 33(4), 920–922.
12 (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapoB-lipoprotein-depleted plasma (FER HDL). Clinical Biochemistry. 34(7), 583–588.
13 (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41(6), 1313–1321.
14 (2009) Effects of Ramadan fasting on some haematological and biochemical parameters. Jordan J Biol Sci. 2(3), 103–108.
15 (2015) Effects of Ramadan fasting on serum amyloid A and protein carbonyl group levels in patients with cardiovascular diseases. Journal of Cardiovascular and Thoracic Research. 7(2), 55.
16 (2016) Ramadan fasting decreases body fat but not protein mass. International Journal of Endocrinology and Metabolism. 14(1).
17 (2012) Impact of Ramadan Intermittent Fasting on Oxidative Stress Measured by Urinary 15-F2t-Isoprostane.
18 (2013) Effect of fasting in Ramadan on body composition and nutritional intake: a prospective study. Journal of Human Nutrition and Dietetics. 26(S1), 97–104.
19 (2014) Does Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysis. Journal of Religion and Health. 53(3), 929–942.
20 (2008) Effect of Ramadan fasting on some indices of insulin resistance and components of the metabolic syndrome in healthy male adults. British Journal of Nutrition. 100(1), 147.
21 (2012) Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutrition Research. 32(12), 947–955.
22 (2012) Visceral adiposity index is associated with significant fibrosis in patients with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 35(2), 238–247.
23 (2014) Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. Clinical Endocrinology. 81(3), 426–431.
24 (2013) The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity. 21(8), 1690–1694.
25 (2013) Impact of religious Ramadan fasting on cardiovascular disease: a systematic review of the literature. Current Medical Research and Opinion. 29(4), 343–354.
26 (2006) The changes of metabolic profile and weight during Ramadan fasting. Singapore Medical Journal. 47(5), 409.
27 (2015) Atkins diet program rapidly decreases atherogenic index of plasma in trained adapted overweight men. Archives of Endocrinology and Metabolism. 0–0.(AHEAD)
28 (2015) Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease. Medical Journal of the Islamic Republic of Iran. 29, 240.
29 (2014) Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio. The American Journal of Medicine. 127(2), 152–157.
30 (2013) Atherogenic index of plasma, castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk. Int J Pharm Biol Sci. 3(3), 359–364.
31 (2016) Serum levels of Lp (a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities. Scandinavian Journal of Clinical and Laboratory Investigation. 1–9.
32 (2011) Effects of Ramadan fasting on biochemical and hematological parameters and cytokines in healthy and obese individuals. Metabolic Syndrome and Related Disorders. 9(2), 157–161.
33 (2015) The effect of Ramadan fasting on non-alcoholic fatty liver disease (NAFLD) patients: a prospective observational study. Journal of Fasting and Health. 3(2), 74–80.
34 (2016) Effect of weight loss, diet, exercise, and bariatric surgery on nonalcoholic fatty liver disease. Clinics in Liver Disease. 20(2), 339–350.